PRKCA and neoplasm: Morphoproteomic analysis by immunohistochemistry was performed by the Brown Laboratory at the University of Texas Health Science Center Houston [12] and focused on the higher-grade portion of the tumor which showed IGF1R and PRKCA as the principal upstream signal transducer drivers and mTOR as a downstream effector.